Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
for
Gestational Diabetes Mellitus in Pregnancy
Location: Cleveland OH, Philadelphia PA, New York NY, Decatur GA,
Sponsor: Jaeb Center for Health Research
Sex: Female
Age: 18+
Code: NCT06957028
Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
for
Progressive Metastatic Castrate Resistant Prostate Cancer
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
for
Immunoglobulin G4 Related Disease
Location: Cleveland OH, Middleburg Heights OH, Detroit MI,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07190196
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Cleveland OH, Parma OH, Beachwood OH,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase3, Recruiting
Preoperative BOTOX® Injection for Large Ventral Hernia Repair
for
Hernia Abdominal Wall, Botox Injection,
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07220382
Recruiting
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
for
Choline Deficiency, Liver Injury
Location: Cleveland OH, Chicago IL, Durham NC, Miami Lakes FL,
Sponsor: Protara Therapeutics
Sex: All
Age: 12+
Code: NCT06910943
Phase2, Phase3, Recruiting
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Cleveland OH, Pittsburgh PA, Philadelphia PA,